IKANOS: A Prospective, Open-Label, Minimally Interventional Hybrid Study in the US Comparing Initiation of Breztri Maintenance versus Any Non-Triple Inhaled Therapy at Discharge after a Hospitalization for a COPD Exacerbation

Objective

Clinical trial details>>

Principal Investigator(s)
Fady Jamous, MD

Clinical Trial Categories

  • Pulmonology
Sponsor(s)
AstraZeneca
Contact
Avera Research Institute at 605-504-3154
or ARI@Avera.org

Location

  • Avera Research Institute — Sioux Falls
    6001 S Sharon Ave
    Sioux Falls, SD 57108
    Main: 605-504-3154